These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 8918758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.
    Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Bréchot C.
    Kidney Int; 1995 May; 47(5):1412-8. PubMed ID: 7637270
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
    Rostaing L, Izopet J, Moussion F, Alric L, Verdier D, That HT, Duffaut M, Durand D, Puel J, Suc JM.
    Nephrologie; 1997 May; 18(7):281-6. PubMed ID: 9496568
    [Abstract] [Full Text] [Related]

  • 9. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S, Craxì A, Fabiano C, Fiorentino G, Marino L, Almasio P, Pinzello GB, Palazzo U, Vitale M, Maggio A.
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G.
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF, Elste C, Dienes HP, Michel G, Braun HB, Meyer zum Büschenfelde KH, Gerken G.
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [Abstract] [Full Text] [Related]

  • 14. Treatment of HCV liver disease by recombinant interferon alpha.
    Bailly F, Si N, Si A, Trepo C.
    Nephrol Dial Transplant; 1996 Sep; 11 Suppl 4():56-7. PubMed ID: 8918757
    [Abstract] [Full Text] [Related]

  • 15. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
    Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH.
    Ann Intern Med; 1991 Nov 01; 115(9):700-4. PubMed ID: 1656828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.
    Orito E, Mizokami M, Suzuki K, Ohba KI, Ohno T, Mizuno M, Iijima Y, Saito H, Nemoto A, Nukuta N.
    J Gastroenterol Hepatol; 1997 Jan 01; 12(1):58-61. PubMed ID: 9076625
    [Abstract] [Full Text] [Related]

  • 18. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J.
    Rev Esp Enferm Dig; 1997 Jul 01; 89(7):531-50. PubMed ID: 9265839
    [Abstract] [Full Text] [Related]

  • 19. Mooren-type hepatitis C virus-associated corneal ulceration.
    Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA.
    Ophthalmology; 1994 Apr 01; 101(4):736-45. PubMed ID: 7512254
    [Abstract] [Full Text] [Related]

  • 20. Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.
    Kondo M, Tanaka K, Ikeda M, Arata S, Saito S, Sakaguchi T, Morimoto M, Fujii T, Mitsui K, Okazaki H, Hoshino M, Sekihara H.
    J Gastroenterol Hepatol; 1996 Mar 01; 11(3):236-40. PubMed ID: 8742919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.